A detailed history of Putnam Investments LLC transactions in Dyne Therapeutics, Inc. stock. As of the latest transaction made, Putnam Investments LLC holds 39,536 shares of DYN stock, worth $1.13 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
39,536
Previous 36,737 7.62%
Holding current value
$1.13 Million
Previous $329,000 59.57%
% of portfolio
0.0%
Previous 0.0%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 14, 2024

BUY
$6.62 - $13.64 $18,529 - $38,178
2,799 Added 7.62%
39,536 $525,000
Q3 2023

Nov 14, 2023

SELL
$8.6 - $12.18 $2,691 - $3,812
-313 Reduced 0.84%
36,737 $329,000
Q2 2023

Aug 14, 2023

SELL
$8.53 - $14.28 $9,826 - $16,450
-1,152 Reduced 3.02%
37,050 $416,000
Q1 2023

May 22, 2023

SELL
$10.88 - $15.0 $17,582 - $24,240
-1,616 Reduced 4.06%
38,202 $440,000
Q4 2022

Feb 14, 2023

BUY
$9.37 - $13.8 $373,094 - $549,488
39,818 New
39,818 $461,000

Others Institutions Holding DYN

About Dyne Therapeutics, Inc.


  • Ticker DYN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 51,765,400
  • Market Cap $1.47B
  • Description
  • Dyne Therapeutics, Inc., a muscle disease company, operates as a biotechnology company that focuses on advancing therapeutics for genetically driven muscle diseases in the United States. It develops various programs for myotonic dystrophy type 1, duchenne muscular dystrophy, and facioscapulohumeral dystrophy, as well as rare skeletal muscle, and...
More about DYN
Track This Portfolio

Track Putnam Investments LLC Portfolio

Follow Putnam Investments LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Putnam Investments LLC, based on Form 13F filings with the SEC.

News

Stay updated on Putnam Investments LLC with notifications on news.